title: Higher prevalence of obesity and overweight without an adverse metabolic profile in girls with central precocious puberty compared to girls with early puberty, regardless of GnRH analogue treatment.
abstract: OBJECTIVE
  1. To determine BMI, obesity/overweight rates, glucose and lipids at baseline, during GnRHa treatment and shortly after therapy discontinuation in female children with CPP and EP. 2. To compare this response to that seen in a similar group of untreated patients.
  
  
  METHODS
  A retrospective analysis of 71 children with either CPP (n = 37) or EP (n = 34) was undertaken. Forty three were treated with a GnRHa for at least 2 years, while 28 were followed without treatment.
  
  
  RESULTS
  At the time of diagnosis, a higher BMI (z-score of 1.1 ± 0.8 vs. 0.6 ± 0.7, p = 0.004) and a higher prevalence of obesity/overweight (72.9 vs. 35.3%, p = 0.001) was observed in subjects with CPP when compared to those with EP. Children with EP had higher fasting glucose and total cholesterol than those with CPP. BMI z-score, obesity/overweight rates, fasting glucose and lipids did not change significantly in girls with CPP or EP during 3 yrs of follow up, regardless of treatment. Weight z-scores were higher at 3 years in treated than in untreated girls with CPP (p = 0.02), while it was higher in untreated than in GnRHa-treated patients with EP at baseline, 1, 2 and 3 years (p = 0.007, p = 0.002, p = 0.02 and p = 0.04, respectively) and remained so shortly after stopping therapy (p = 0.03).
  
  
  CONCLUSIONS
  There is a high prevalence of obesity/overweight in girls with CPP and EP at diagnosis. However, this risk is greater in CPP than in EP girls. BMI, Obesity/overweight rates, fasting glucose and lipids remained stable in CPP and EP girls regardless of therapy. Weight z-scores were found to be higher in treated CPP girls and in untreated girls with EP.
authors.affiliation: Department of Pediatrics, Hospital Dr. Patrocinio Peñuela-IVSS, San Cristobal, Táchira 5001, Venezuela.
authors.forename: Ana
authors.initials: A
authors.lastname: Colmenares
authors.affiliation: Pediatric Endocrine Unit, Hospital de Clínicas Caracas, Caracas, Venezuela.
authors.forename: Peter
authors.initials: P
authors.lastname: Gunczler
authors.affiliation: Pediatric Endocrine Unit, Hospital de Clínicas Caracas, Caracas, Venezuela.
authors.forename: Roberto
authors.initials: R
authors.lastname: Lanes
keywords: BMI; Central precocious puberty; Early puberty; Glucose; GnRHa; Lipids; Overweight and obesity rates
references.citation: J Clin Endocrinol Metab. 1999 Jan;84(1):44-9
references.pmid: 9920060
references.citation: Fertil Steril. 1993 Sep;60(3):456-60
references.pmid: 8375526
references.citation: J Clin Endocrinol Metab. 2007 Sep;92(9):3483-9
references.pmid: 17579199
references.citation: Pediatr Diabetes. 2008 Oct;9(5):464-71
references.pmid: 18507788
references.citation: J Clin Endocrinol Metab. 2002 May;87(5):2090-4
references.pmid: 11994346
references.citation: Eur J Endocrinol. 2004 Apr;150(4):533-7
references.pmid: 15080784
references.citation: N Engl J Med. 1997 Sep 25;337(13):869-73
references.pmid: 9302300
references.citation: J Pediatr Endocrinol Metab. 2006 Nov;19(11):1327-34
references.pmid: 17220061
references.citation: Horm Res Paediatr. 2011;75(3):174-9
references.pmid: 20881364
references.citation: Pediatr Endocrinol Diabetes Metab. 2009;15(1):7-11
references.pmid: 19454183
references.citation: Pediatrics. 2003 Apr;111(4 Pt 1):815-21
references.pmid: 12671118
references.citation: J Clin Endocrinol Metab. 2010 Jan;95(1):109-17
references.pmid: 19897682
references.citation: J Clin Endocrinol Metab. 1998 Feb;83(2):370-3
references.pmid: 9467543
references.citation: Rev Med Brux. 2005 Feb;26(1):27-32
references.pmid: 15816337
references.citation: Turk J Pediatr. 2011 Jan-Feb;53(1):27-33
references.pmid: 21534336
references.citation: Clin Endocrinol (Oxf). 2004 Nov;61(5):626-34
references.pmid: 15521967
references.citation: J Clin Endocrinol Metab. 2010 Aug;95(8):3736-44
references.pmid: 20484471
references.citation: Eur J Endocrinol. 2005 Sep;153(3):463-4
references.pmid: 16131610
references.citation: Clin Chem. 1972 Jun;18(6):499-502
references.pmid: 4337382
references.citation: J Clin Endocrinol Metab. 2002 Feb;87(2):506-12
references.pmid: 11836277
references.citation: J Pediatr Endocrinol Metab. 2000 Jul;13 Suppl 1:773-80
references.pmid: 10969920
references.citation: J Clin Endocrinol Metab. 2008 Jan;93(1):190-5
references.pmid: 17940112
references.citation: J Clin Endocrinol Metab. 1999 Dec;84(12):4480-8
references.pmid: 10599706
references.citation: Neuroendocrinology. 2009;89(4):441-7
references.pmid: 19176945
references.citation: J Clin Endocrinol Metab. 1999 Dec;84(12):4583-90
references.pmid: 10599723
references.citation: Zhongguo Dang Dai Er Ke Za Zhi. 2009 May;11(5):374-6
references.pmid: 19470261
references.citation: Eur J Endocrinol. 2010 Jul;163(1):55-62
references.pmid: 20356934
references.citation: Pediatrics. 2009 Apr;123(4):e752-62
references.pmid: 19332438
references.citation: Pediatrics. 2007 Mar;119(3):e624-30
references.pmid: 17332182